Don't consider selling before profitability, page-208

Yes it's definitely a lot of growth and a serious challenge. But the huge increase in accounts means it is a very real possibility and the product has such an obvious benefit that I believe the uptake will be significant. I also think with the current valuation the company is not being bid to the stars. I look at a company like Disc Medicine and scratch my head. Obviously it's not an apples with apples comparison being a pharmaceutical company but they have no approved drug and are going after a relatively small indication with their lead candidate and are years from approval. Their market cap is currently over three times Avita's and whilst Avita has a way to go to make good money the story is there for a market cap several times higher than where we're at.

All that said, like Saltland here, I would love to see a BARDA contract with a bit of beef to help things along. I have no understanding of the process behind that but if there was one for burns surely FTSD makes sense too.